Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_assertion description "[Fibroblast growth factor 21 (FGF21) is a distinctive member of the FGF family with potent beneficial effects on lipid, body weight, and glucose metabolism and has attracted considerable interest as a potential therapeutic for treating diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_assertion evidence source_evidence_literature NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_assertion SIO_000772 23197570 NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_assertion wasDerivedFrom befree-20140225 NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_assertion wasGeneratedBy ECO_0000203 NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.
- befree-20140225 importedOn "2014-02-25" NP892932.RATVC5BvmT84OvK0rO7F8iAMuVpeBKZ3rTRBqdoExyA44130_provenance.